Monod Bio | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

Monod Bio is a pioneer company in the design of de novo protein biosensors, utilizing advanced computational protein engineering...


Monod Bio LinkedIn profile Monod Bio X profile
Monod Bio logo

Monod Bio is a pioneer company in the design of de novo protein biosensors, utilizing advanced computational protein engineering to create innovative biosensing nanoswitches. The company focuses on developing sensitive detection methods for proteins, peptides, and small molecules, positioning itself at the forefront of biosensor innovation in the biotechnology research industry.

Website
Headquarters
Seattle, Washington
Size
11-50 employees
Industry
Biotechnology Research

🛍️ Monod Bio Product and Pricing News →

👔 Monod Bio CEO, Management and Leadership Team →

⚔️ Monod Bio Alternatives and Competitors →

💼 Monod Bio Hiring and Layoffs →

🤖 Monod Bio Developer, Integration and Automation News →

📈 Monod Bio Financials, Fundraising and Valuation News →

Monitor your competitors, key accounts, or your own company with RivalSense AI

🛍️ Monod Bio Product and Pricing News

  • Carl Walkey, Senior Director of Business Development at Monod Bio, presented the company's platform technologies at the Life Science Innovation Northwest conference on April 24.


👔 Monod Bio CEO, Management and Leadership Team

  • Daniel-Adriano S.
    CEO and President
    undefined


⚔️ Monod Bio Alternatives and Competitors

  • Henry Ford Health System
  • |
  • BionPharma
  • |
  • Foldink
  • |
  • Bonum Therapeutics
  • |
  • Aclys Bio
  • |
  • ABG Biotech
  • |
  • Pctaire
  • |
  • Sherlock Biosciences
  • |
  • DIA Sensor
  • |
  • Mercury Biomed
  • |
  • FOx Biosystems
  • |
  • Cam Med

Monitor your competitors, key accounts, or your own company with RivalSense AI


💼 Monod Bio Hiring and Layoffs


🤖 Monod Bio Developer, Integration and Automation News


📈 Monod Bio Financials, Fundraising and Valuation News


People also viewed